Loss of heterozygosity and human telomerase reverse transcriptase (hTERT) expression in bronchial mucosa of heavy smokers

Cancer

Volumn 109, Issue 11, 2007, Pages 2299-2307

  Capkova, Linda ^a,b   Kalinova, Marketa ^a   Krskova, Lenka ^a   Kodefova, Daniela ^a   Petrik, Frantisek ^b   Trefny, Martin ^b   Musil, Jaromir ^b   Kodet, Roman ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Heavy smokers; hTERT mRNA expression; Loss of heterozygosity; Precancerous lesions; Telomerase

Indexed keywords

MESSENGER RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; ARTICLE; BRONCHITIS; BRONCHOSCOPY; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CAPILLARY ELECTROPHORESIS; DYSPLASIA; ENZYME ACTIVITY; FEMALE; FLUORESCENCE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOGENESIS; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING HABIT; SQUAMOUS CELL METAPLASIA;

BRONCHI; CARCINOMA, BRONCHOGENIC; EPITHELIAL CELLS; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; METAPLASIA; MUCOUS MEMBRANE; PRECANCEROUS CONDITIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMOKING; TELOMERASE;

EID: 34249090269     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22683     Document Type: Article

References (38)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. Brambilla C, Fievet F, Jeanmart M, et al. Early detection of lung cancer: role of biomarkers. Eur Respir J Suppl. 2003;39:36s-44s.
3. Niklinski J, Niklinska W, Chyczewski L, Becker HD, Pluygers E. Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications. Eur J Cancer Prev. 2001;10:213-226.
4. Wistuba, II, Behrens C, Milchgrub S, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene. 1999;18:643-650.
5. Mao L, Lee JS, Kurie JM, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst. 1997;89:857-862.
6. Auerbach O, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. N Engl J Med. 1979;300:381-385.
7. Travis WD BE, Muller-Hermelink HK, Harris CC. Tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004.
8. Sutedja G. New techniques for early detection of lung cancer. Eur Respir J Suppl. 2003;39:57s-66s.
9. Wistuba, II, Lam S, Behrens C, et al. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst. 1997;89:1366-1373.
10. Gafa R, Maestri I, Matteuzzi M, et al. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability. Cancer. 2000;89:2025-2037.
11. Stefansson I, Akslen LA, MacDonald N, et al. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study. Clin Cancer Res. 2002;8:138-143.
12. Geisler JP, Goodheart MJ, Sood AK, Holmes RJ, Hatterman-Zogg MA, Buller RE. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. Cancer 2003;98:2199-2206.
13. Woenckhaus M, Stoehr R, Dietmaier W, et al. Microsatellite instability at chromosome 8p in non-small cell lung cancer is associated with lymph node metastasis and squamous differentiation. Int J Oncol. 2003;23:1357-1363.
14. Hirao T, Nelson HH, Ashok TD, et al. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer. Cancer Res. 2001;61:612-615.
15. Xinarianos G, Liloglou T, Prime W, et al. hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. Cancer Res. 2000;60:4216-4221.
16. Sozzi G, Pastorino U, Moiraghi L, et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res. 1998;58:5032-5037.
17. Brambilla E, Gazzeri S, Moro D, Lantuejoul S, Veyrenc S, Brambilla C. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions. Clin Cancer Res. 1999;5:243-250.
18. Rasio D, Negrini M, Manenti G, Dragani TA, Croce CM. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. Cancer Res. 1995;55:3988-3991.
19. Tran YK, Newsham IF. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas. Cancer Res. 1996;56:2916-2921.
20. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst. 1995;87:884-894.
21. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349-352.
22. Artandi SE. Telomeres, telomerase, and human disease. N Engl J Med. 2006;355:1195-1197.
23. Liu L, Lai S, Andrews LG, Tollefsbol TO. Genetic and epigenetic modulation of telomerase activity in development and disease. Gene. 2004;340:1-10.
24. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science. 1997;277:955-959.
25. Arinaga M, Shimizu S, Gotoh K, et al. Expression of human telomerase subunit genes in primary lung cancer and its clinical significance. Ann Thorac Surg. 2000;70:401-405; discussion 405-406.
26. Shibuya K, Fujisawa T, Hoshino H, et al. Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung. Cancer. 2001;92:849-855.
27. Medintz IL, Lee CC, Wong WW, Pirkola K, Sidransky D, Mathies RA. Loss of heterozygosity assay for molecular detection of cancer using energy-transfer primers and capillary array electrophoresis. Genome Res. 2000;10:1211-1218.
28. Powell CA, Klares S, O'Connor G, Brody JS. Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer. Clin Cancer Res. 1999;5:2025-2034.
29. Wang Y, Hung SC, Linn JF, et al. Microsatellite-based cancer detection using capillary array electrophoresis and energy-transfer fluorescent primers. Electrophoresis. 1997;18:1742-1749.
30. Bijwaard KE, Aguilera NS, Monczak Y, Trudel M, Taubenberger JK, Lichy JH. Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma. Clin Chem. 2001;47:195-201.
31. Kumaki F, Kawai T, Hiroi S, et al. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas. Hum Pathol. 2001;32:188-195.
32. Counter CM, Meyerson M, Eaton EN, et al. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene. 1998;16:1217-1222.
33. Snijders PJ, Breuer RH, Sutedja TG, et al. Elevated hTERT mRNA levels: A potential determinant of bronchial squamous cell carcinoma (in situ). Int J Cancer. 2004:109:412-417.
34. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
35. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer. 1997;33:787-791.
36. Belair CD, Yeager TR, Lopez PM, Reznikoff CA. Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci U S A. 1997;94:13677-13682.
37. Yim HW, Slebos RJ, Randell SH, et al. Smoking is associated with increased telomerase activity in short-term cultures of human bronchial epithelial cells. Cancer Lett. 2007;246:24-33.
38. Malhotra P, Behera D, Srinivasan R, et al. Detection of microsatellite alterations in bronchial washings in squamous cell lung cancer: the first study from India. Jpn J Clin Oncol. 2004;34:439-444.